Welcome to our dedicated page for Enhabit SEC filings (Ticker: EHAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Enhabit, Inc. filings document formal disclosures for a public home health and hospice care provider. Recent reports include 8-K material-event disclosures, Regulation FD materials, operating and financial results, risk-factor updates, shareholder voting matters and capital-structure information.
The company’s SEC record also covers material definitive agreements, including credit facilities and related debt terms, governance matters such as officer transitions, and litigation-related disclosures involving claims connected to its home health and hospice business history. These filings frame Enhabit’s regulatory reporting around healthcare operations, financing arrangements, corporate governance and stockholder matters.
Enhabit, Inc. executive Jeanne Louise Kalvaitis, EVP of Hospice Operations, reported an amended Form 4 reflecting a prior stock award. She acquired 6,724 shares of common stock as a grant at a price of $13.61 per share. Following this acquisition, she directly holds 61,875 common shares. A footnote explains the award was omitted from the original filing due to a clerical error, and this amendment corrects that omission.
Jolley Julie Diane reported acquisition or exercise transactions in this Form 4 filing.
Enhabit, Inc. executive Julie Diane Jolley, EVP of Home Health Operations, reported an amended insider filing reflecting a grant of common stock. She received 12,050 shares of Enhabit common stock on March 6, 2026 at a stated value of $13.61 per share as a stock award, increasing her direct holdings to 142,716 shares after the transaction. The amendment notes this award was originally omitted due to a clerical error, so the filing updates previously reported ownership rather than recording an open-market purchase or sale.
Black Dylan C reported acquisition or exercise transactions in this Form 4 filing.
Enhabit, Inc. reported that its General Counsel and Secretary, Dylan C. Black, received a grant of 11,463 shares of common stock on March 6, 2026 at $13.61 per share. This award increased his direct holdings to 99,823 shares of common stock. The amended Form 4 corrects a clerical error, noting that this award had been omitted from the original filing.
Enhabit, Inc. executive Collin McQuiddy, the Chief Accounting Officer, reported a routine tax-related share disposition. On the vesting of restricted stock, 592 shares of common stock were withheld at $13.61 per share to cover tax withholding obligations. After this non-market transaction, McQuiddy directly holds 5,394 common shares.
Enhabit, Inc. Chief Financial Officer Solomon Ryan reported routine equity compensation and related tax withholding transactions in company common stock. On March 6, 2026, he received a grant of 12,859 shares of common stock at $13.61 per share as a compensation award. On the same day, 5,127 shares were disposed of at $13.61 per share to satisfy tax withholding obligations tied to the vesting of related restricted stock. On March 7, 2026, an additional 3,882 shares were withheld at $13.61 per share for tax obligations. After these transactions, he directly held 175,541 shares of Enhabit common stock.
Enhabit, Inc. Chief Human Resources Officer Tanya Renee Marion reported compensation-related stock transactions in company common shares. She received a grant of 9,001 shares of common stock at $13.61 per share. On the same date and the following day, a total of 5,240 shares were withheld at $13.61 per share to cover tax obligations tied to the vesting of restricted stock, rather than being sold on the open market. After these transactions, she directly holds 93,052 shares, and an additional 1,712 shares are held indirectly by her spouse.
Enhabit, Inc. executive Jeanne Louise Kalvaitis, EVP of Hospice Operations, reported routine equity compensation and related tax withholding transactions in company common stock. On March 6, 2026, she received a grant/award of 5,603 shares at $13.61 per share, increasing her direct holdings to 57,351 shares. That same day, 1,365 shares were disposed of at $13.61 per share to satisfy tax withholding obligations tied to vesting restricted stock, as noted in the footnote. On March 7, 2026, a further 835 shares were similarly disposed of at $13.61 per share for tax withholding. After these compensation-related transactions, Kalvaitis directly holds 55,151 shares of Enhabit common stock. These dispositions reflect tax payments rather than open-market trading activity.
Enhabit, Inc. executive Julie Diane Jolley, EVP of Home Health Operations, reported routine equity compensation activity. On March 6, she received a grant of 10,030 shares of common stock at $13.61 per share. On March 6 and 7, a total of 6,608 shares were disposed of at the same price to cover tax withholding obligations tied to restricted stock vesting, as noted in the footnote. After these transactions, she directly holds 130,666 shares of Enhabit common stock.
Enhabit, Inc. President and CEO Barbara Ann Jacobsmeyer reported routine equity compensation and related tax transactions in company common stock. On March 6, 2026, she received a grant of 32,789 shares at $13.61 per share. On March 6 and March 7, a total of 12,903 and 17,516 shares were withheld or surrendered at the same price to cover tax withholding obligations tied to vesting restricted stock, rather than open-market sales. After these transactions, she directly owned 606,707 shares of Enhabit common stock.